VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 52 filers reported holding VERRICA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | -33.3% | 300 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q2 2021 | $3,000 | -25.0% | 300 | 0.0% | 0.00% | – |
| Q1 2021 | $4,000 | +33.3% | 300 | 0.0% | 0.00% | – |
| Q4 2020 | $3,000 | +50.0% | 300 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | -88.9% | 300 | -82.4% | 0.00% | – |
| Q2 2020 | $18,000 | 0.0% | 1,700 | 0.0% | 0.00% | – |
| Q1 2020 | $18,000 | -33.3% | 1,700 | 0.0% | 0.00% | – |
| Q4 2019 | $27,000 | -46.0% | 1,700 | -50.0% | 0.00% | – |
| Q3 2019 | $50,000 | +163.2% | 3,400 | +100.0% | 0.00% | – |
| Q2 2019 | $19,000 | +5.6% | 1,700 | 0.0% | 0.00% | – |
| Q1 2019 | $18,000 | +38.5% | 1,700 | 0.0% | 0.00% | – |
| Q4 2018 | $13,000 | -51.9% | 1,700 | 0.0% | 0.00% | – |
| Q3 2018 | $27,000 | – | 1,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Altium Capital Management LP | 562,954 | $8,529,000 | 2.37% |
| Perceptive Advisors | 3,610,412 | $54,698,000 | 0.69% |
| KNOTT DAVID M | 78,424 | $1,188,000 | 0.51% |
| Monashee Investment Management LLC | 200,000 | $3,030,000 | 0.47% |
| Fosun International Ltd | 282,408 | $4,279,000 | 0.34% |
| Parian Global Management LP | 39,560 | $599,000 | 0.27% |
| Orbimed Advisors | 1,479,733 | $22,418,000 | 0.21% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 719,836 | $10,906,000 | 0.18% |
| SteelPeak Wealth, LLC | 132,961 | $2,014,000 | 0.16% |
| Pinz Capital Management, LP | 13,422 | $203,000 | 0.05% |